Actinomyces Predicts Immune Therapy Success in Lung Cancer
In a groundbreaking study soon to be published, researchers have unveiled a vital connection between salivary microbial signatures and the ...
Tag: NSCLC
M2 Macrophages Shape CD8+ T Cell Response in NSCLC
Recent advancements in cancer immunotherapy have highlighted the crucial role of tumor microenvironment components, particularly M2 macrophages, in shaping the ...
Osimertinib Resistance and EGFR Mutations in NSCLC Treatment
The presence of the T790M mutation during first or second-generation EGFR-TKI treatments is observed in 50-60% of patients. This mutation ...
Advances in NSCLC Treatment – Overcoming Osimertinib Resistance and Exploring the Potential of Amivantamab and Lazertinib
In the ever-evolving landscape of cancer treatment, recent breakthroughs in the fight against non-small cell lung cancer (NSCLC) have brought ...
Fighting Osimertinib Resistance in Lung Cancer Treatment
Lung cancer remains one of the leading causes of cancer-related deaths worldwide. Among its types, non-small cell lung cancer (NSCLC) ...
